Panadol’s continuing dominance proves a pain for competitors

Original article by Roy Morgan
Market Research Update – Page: Online : 6-Aug-19

New research from Roy Morgan shows that 12.4 million Australians aged 14+ (60.4%) purchased headache and pain relief products in an average four weeks in the year to March 2019, up from 12.1 million in 2016. Some 7.8 million Australians (38% of the population) purchase Panadol-brand pain relief products in an average four weeks, followed by Nurofen (21.8%) and supermarket brands (9.9%). The research also shows that over the past three years, the proportion of Australians who purchase Panadol has increased by 0.8% points, while Nurofen has decreased by 1.2% points. Meanwhile, 30.1% of Australians indicate that they buy pain relief products from chemists or pharmacies in an average six months, while supermarkets are the next preferred choice (26%).

CORPORATES
ROY MORGAN LIMITED

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s